Pharming (PHAR) Change in Receivables (2020 - 2025)
Historic Change in Receivables for Pharming (PHAR) over the last 7 years, with Q3 2025 value amounting to $43.6 million.
- Pharming's Change in Receivables fell 952.92% to $43.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.6 million, marking a year-over-year decrease of 952.92%. This contributed to the annual value of $54.8 million for FY2024, which is 1877.25% up from last year.
- Latest data reveals that Pharming reported Change in Receivables of $43.6 million as of Q3 2025, which was down 952.92% from $53.3 million recorded in Q2 2025.
- Over the past 5 years, Pharming's Change in Receivables peaked at $54.8 million during Q4 2024, and registered a low of -$1.5 million during Q4 2022.
- Its 5-year average for Change in Receivables is $33.0 million, with a median of $37.6 million in 2021.
- Per our database at Business Quant, Pharming's Change in Receivables plummeted by 14937.52% in 2022 and then surged by 14046125.99% in 2023.
- Pharming's Change in Receivables (Quarter) stood at $3.0 million in 2021, then plummeted by 149.38% to -$1.5 million in 2022, then skyrocketed by 3257.18% to $46.2 million in 2023, then increased by 18.77% to $54.8 million in 2024, then decreased by 20.46% to $43.6 million in 2025.
- Its last three reported values are $43.6 million in Q3 2025, $53.3 million for Q2 2025, and $47.5 million during Q1 2025.